cannabidiol

Opioid addiction market to reach $2.4 billion by 2033 amid rising cases and new non-opioid treatments, despite generic erosion

The scheme provides a financial incentive to 55 selected applicants for manufacturing of identified products under three…

Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…